These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 31197958)

  • 21. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
    Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
    Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
    BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.
    Chang WL; Yang WC; Zeng XY; Li CG; Xiong Z; Wang T; Zhang RZ; Tao KX; Zhang P
    BMC Gastroenterol; 2020 Apr; 20(1):124. PubMed ID: 32321434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
    Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
    Matsas S; Aguiar PN; Del Giglio A
    J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients.
    Huszno J; Kołosza Z; Mrochem-Kwarciak J; Zajusz A
    Oncology; 2020; 98(7):487-492. PubMed ID: 32344419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis.
    Ni L; Tao J; Xu J; Yuan X; Long Y; Yu N; Wu R; Zhang Y
    Arch Gynecol Obstet; 2020 Jan; 301(1):251-261. PubMed ID: 31768743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
    Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
    Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Pre-Treatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Brain Metastasis From Lung Cancer: A systematic Review and Meta-Analysis.
    Li Z; Zhang W; Wu S
    Altern Ther Health Med; 2024 Jul; 30(7):108-113. PubMed ID: 37944973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis.
    Wei ZW; Huang WB; Yang DJ; Yuan YJ; He YL; Zhang CH
    Transl Cancer Res; 2020 Sep; 9(9):5128-5138. PubMed ID: 35117879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Turri-Zanoni M; Salzano G; Lambertoni A; Giovannardi M; Karligkiotis A; Battaglia P; Castelnuovo P
    Head Neck; 2017 Apr; 39(4):730-736. PubMed ID: 28032937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor].
    Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of The Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Platelet Count for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer.
    Sowannakul A; Rodpenpear N; Ekbhum P; Tantitamit T
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3765-3771. PubMed ID: 38019234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study.
    Hao L; Dong J; Yu H; Chen J; Han X; Pan Y
    Transl Cancer Res; 2023 Oct; 12(10):2726-2741. PubMed ID: 37969380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
    Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
    Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.